AR and renal cell carcinoma: Zhu et al. [21] confirmed that there is no statistically significant difference in the rate of AR-positive RCC in men and women, showing that women with RCC have tumors expressing the AR in the same fashion as men, and that this receptor’s expression is associated with worse outcomes and more aggressive features.